相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of 68Ga-Prostate-Specific Membrane Antigen PET/CT on Prostate Cancer Management
Asim Afaq et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Prostate-specific antigen after salvage radiotherapy for postprostatectomy biochemical recurrence predicts long-term outcome including overall survival
Detlef Bartkowiak et al.
ACTA ONCOLOGICA (2018)
Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer
Pim J. van Leeuwen et al.
BJU INTERNATIONAL (2017)
The Clinical Impact of Additional Late PET/CT Imaging with 68Ga-PSMA-11 (HBED-CC) in the Diagnosis of Prostate Cancer
Ali Afshar-Oromieh et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Treatment Outcomes from 68Ga-PSMA PET/CT-Informed Salvage Radiation Treatment in Men with Rising PSA After Radical Prostatectomy: Prognostic Value of a Negative PSMA PET
Louise Emmett et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
68Ga-PSMA-PET for radiation treatment planning in prostate cancer recurrences after surgery: Individualized medicine or new standard in salvage treatment
Gregor Habl et al.
PROSTATE (2017)
Intermediate-term outcome after PSMA-PET guided high-dose radiotherapy of recurrent high-risk prostate cancer patients
Sebastian Zschaeck et al.
RADIATION ONCOLOGY (2017)
Initial multicentre experience of 68gallium-PSMA PET/CT guided robot-assisted salvage lymphadenectomy: acceptable safety profile but oncological benefit appears limited
Amila Siriwardana et al.
BJU INTERNATIONAL (2017)
Clinical impact of 68Ga-prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in patients with prostate cancer with rising prostate-specific antigen after treatment with curative intent: preliminary analysis of a multidisciplinary approach
Simone Albisinni et al.
BJU INTERNATIONAL (2017)
Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)
Gregor Habl et al.
BMC CANCER (2017)
68Ga-PSMA Ligand PET/CT-based Radiotherapy for Lymph Node Relapse of Prostate Cancer After Primary Therapy Delays Initiation of Systemic Therapy
Christoph Henkenberens et al.
ANTICANCER RESEARCH (2017)
68Ga-PSMA-11 PET/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patients
Florian Sterzing et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
68Ga-PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment
Pim J. van Leeuwen et al.
BJU INTERNATIONAL (2016)
68Ga-PSMA I&T PET/CT for assessment of prostate cancer: evaluation of image quality after forced diuresis and delayed imaging
Thorsten Derlin et al.
EUROPEAN RADIOLOGY (2016)
Sensitivity, Specificity, and Predictors of Positive 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis
Marlon Perera et al.
EUROPEAN UROLOGY (2016)
Salvage Radiation Therapy Dose Response for Biochemical Failure of Prostate Cancer After Prostatectomy-A Multi-Institutional Observational Study
Thomas M. Pisansky et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy
Rahul D. Tendulkar et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Diagnostic Efficacy of 68Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer
Tobias Maurer et al.
JOURNAL OF UROLOGY (2016)
Optimal timing of salvage radiotherapy for biochemical recurrence after radical prostatectomy: is ultra-early salvage radiotherapy beneficial?
Satoru Taguchi et al.
RADIATION ONCOLOGY (2016)
[18F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results
Francesco Pasqualetti et al.
RADIATION ONCOLOGY (2016)
68Ga-PSMA ligand PET/CT-based radiotherapy in locally recurrent and recurrent oligometastatic prostate cancer
Christoph Henkenberens et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2016)
Impact of 68Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomy
Christina Bluemel et al.
EJNMMI RESEARCH (2016)
Prostate-specific Membrane Antigen-radioguided Surgery for Metastatic Lymph Nodes in Prostate Cancer
Tobias Maurer et al.
EUROPEAN UROLOGY (2015)
Acute Toxicity and Quality of Life After Dose-Intensified Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: First Results of the Randomized Trial SAKK 09/10
Pirus Ghadjar et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy
Matthias Eiber et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Prospective Comparison of F-18-Fluoromethylcholine Versus Ga-68-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy
Joshua J. Morigi et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Effect of prostate-specific membrane antigen positron emission tomography on the decision-making of radiation oncologists
Thomas P. Shakespeare
RADIATION ONCOLOGY (2015)
Pelvic MRI findings in relapsed prostate cancer after radical prostatectomy
D. Hernandez et al.
RADIATION ONCOLOGY (2015)
Early Salvage Radiotherapy Following Radical Prostatectomy
David Pfister et al.
EUROPEAN UROLOGY (2014)
Impact of Adjuvant Radiotherapy on Survival of Patients With Node-Positive Prostate Cancer
Firas Abdollah et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Synthesis and preclinical evaluation of DOTAGA-conjugated PSMA ligands for functional imaging and endoradiotherapy of prostate cancer
Martina Weineisen et al.
EJNMMI RESEARCH (2014)
Combination of Adjuvant Hormonal and Radiation Therapy Significantly Prolongs Survival of Patients With pT2-4 pN+ Prostate Cancer: Results of a Matched Analysis
Alberto Briganti et al.
EUROPEAN UROLOGY (2011)
分享论文
